Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Booster Study of SCTV01C and SCTV01E vs Inactivated or mRNA Vaccines
NCT05323461Phase 3Unknown
- Sponsor
- Sinocelltech Group Limited
- Start
- May 2022
- Primary completion
- Oct 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of sctv01c, SCTV01E in coronavirus disease 2019 (COVID-19), sponsored by Sinocelltech Group Limited. Status: unknown.
02
Drugs
sctv01cSCTV01E
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05323461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05323461.